BNBartosz Nowak

Bartosz Nowak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bartosz Nowak has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    DIGITAL HEALTH INNOVATIONS IN CONTEMPORARY HEALTHCARE

    by Maria Sierant, Aleksandra Kowalewska-Kurek, Maria Nowakowska, Miszela Kałachurska, Bartosz Nowak, Martyna Rożek, Mateusz Gural, Kamila Zmysłowska

    Contemporary healthcare systems face severe strains due to aging populations, rising chronic disease rates, and workforce shortages. This review of scientific literature from 2015 to 2025 evaluates how Digital Health innovations address these structural challenges. The digital transformation, anchored by electronic medical records, e-prescriptions, and patient portals-has significantly reduced administrative burdens and medical errors. Furthermore, advancements in Artificial Intelligence, Big Data, and the Internet of Medical Things (IoMT) have enhanced diagnostic accuracy and enabled proactive, home-based care through Remote Patient Monitoring (RPM). Clinical evidence indicates that RPM alone reduces hospitalization rates by 27% and lowers overall system expenditures. Despite persistent barriers such as digital exclusion, data privacy concerns, and algorithmic bias, the responsible integration of these digital solutions remains essential for building efficient, accessible, and sustainable patient-centered healthcare systems.

  • Open Access

    MODERN TECHNOLOGIES FOR GLYCEMIC MONITORING IN PATIENTS WITH DIABETES AS A TOOL FOR REDUCING HYPOGLYCEMIA AND ITS COMPLICATIONS – CLINICAL AND SOCIAL IMPLICATIONS

    by Maria Nowakowska, Oliwia JerzyńsKa, Miszela Kałachurska, Martyna RożeK, Aleksandra Kowalewska-Kurek, Aleksandra Lisowska, Bartosz Nowak, Maria Sierant, Mateusz Gural, Constancia Esther Guy

    Diabetes is one of the most serious health problems of modern times. One of its most dangerous complications is hypoglycemia, defined in most cases as a drop in blood glucose concentration below 70 mg/dl. Recurrent hypoglycemia is associated with a significant increase in patient mortality due to both injuries and cardiovascular and neurological complications. The fear of hypoglycemia alone sometimes paralyzes patients' daily lives. Technological advances have made it possible to replace flawed traditional methods of self-monitoring of blood glucose with systems that enable continuous glucose monitoring, which significantly reduce the frequency and duration of hypoglycemia.The latest methods not only allow for round-the-clock blood glucose monitoring, but also warn the patient of the risk of hypoglycemia based on continuous assessment of blood glucose trends, automatic modification of the insulin dose by the device based on current results, and remote monitoring of the patient by a doctor. The use of modern methods brings long-term socioeconomic benefits in the form of a reduction in the number of severe hypoglycemia episodes and, consequently, hospitalizations and their complications. In addition, CGM systems increase patients' sense of security and control over their disease. However, the use of the latest technological advances also presents challenges for patients in terms of their ability to use new technologies, as well as social and economic constraints that hinder the implementation of the latest treatment methods.

  • Open Access

    THE IMPACT OF DIGITAL COGNITIVE REHABILITATION TOOLS ON THE SOCIAL INTEGRATION OF PEOPLE WITH BRAIN INJURIES

    by Miszela Kałachurska, Martyna Rożek, Constancia Esther Guy, Maria Nowakowska, Aleksandra Lisowska, Bartosz Nowak, Oliwia Jerzyńska, Maria Sierant, Aleksandra Kowalewska-Kurek, Mateusz Gural

    Traumatic brain injury (TBI) is a major global health concern, frequently resulting in persistent cognitive impairments that limit social integration and quality of life. Social integration—defined as meaningful participation in interpersonal relationships, employment, and community life—is strongly influenced by deficits in memory, attention, executive functioning, and social cognition. While traditional cognitive rehabilitation has demonstrated clinical benefits, its accessibility and long-term sustainability are often constrained by cost, resource demands, and reliance on in-person delivery. In recent years, digital cognitive rehabilitation tools, including mobile applications, virtual reality (VR), and tele-rehabilitation platforms, have emerged as promising alternatives that enable scalable, adaptive, and home-based interventions. This narrative review synthesizes current evidence on the impact of digital cognitive rehabilitation on social integration following TBI, with attention to clinical outcomes, socio-economic implications, and technological barriers. Findings suggest that digital interventions are effective in improving core cognitive domains and may indirectly enhance social functioning by supporting communication, self-efficacy, motivation, and participation in daily activities. VR-based approaches, in particular, offer ecologically valid environments that facilitate the transfer of cognitive gains to real-world social contexts. Economic evidence indicates that digital rehabilitation is often cost-effective or cost-saving, reducing healthcare system burden and supporting return-to-work outcomes. However, direct evidence linking digital cognitive rehabilitation to measurable social integration outcomes remains limited, and significant barriers persist related to digital access, usability, literacy, and ethical considerations. Future research should prioritize participation-level outcomes, long-term follow-up, and inclusive implementation strategies to maximize the social and societal benefits of digital rehabilitation after brain injury.

  • Open Access

    IRON DEFICIENCY WITHOUT ANEMIA IN ATHLETES: IMPLICATIONS FOR PERFORMANCE, HEALTH, AND TRAINING

    by Oliwia Jerzyńska, Aleksandra Lisowska, Bartosz Nowak, Maria Nowakowska, Maria Sierant, Aleksandra Kowalewska-Kurek, Constancia Esther Guy, Martyna Rożek, Miszela Kałchurska, Mateusz Gural

    Objectives: This review synthesizes current evidence regarding the impact of IDNA on athletic performance. It also covers physiological mechanisms, diagnostic strategies, as well as potential nutritional and training implications. Methods: The literature search was conducted in the PubMed database. The search terms were related to iron deficiency, iron status, non-anemic states, athletes, performance, and endurance. Athletes with low iron stores and normal hemoglobin concentrations were the subject of this study, which included original research and reviews. Studies consisting of iron deficiency anemia (IDA) or non-athletic populations were excluded from the paper. A narrative synthesis was performed. Key Findings: IDNA is a common condition among athletic populations, which can be associated with reduced aerobic capacity. Affected athletes have a decreased probability of achieving high VO₂-based performance thresholds. Therefore, athletes should be seasonally screened for IDNA using ferritin with CRP. Diagnostic accuracy can be improved by selective use of transferrin saturation and soluble transferrin receptor (sTfR). Iron supplementation efficacy depends on the severity of iron deficiency. Performance benefits are most consistent in individuals with ferritin levels below 20 µg/L. Conclusions: Endurance performance and training efficiency are especially at risk of being negatively affected by IDNA. The research shows that athletes at a higher risk of IDNA should be advised to conduct regular screening. Moreover, there is a lack of analysis focused on ferritin cut-offs and intervention protocols that would benefit athletic populations.

  • Open Access

    GLP-1 RECEPTOR AGONISTS AND COLORECTAL CANCER: BIOLOGICAL PLAUSIBILITY AND CURRENT EVIDENCE

    by Bartosz Nowak, Miszela Kałachurska, Martyna Rożek, Maria Nowakowska, Aleksandra Kowalewska-Kurek, Aleksandra Lisowska, Oliwia Jerzyńska, Maria Sierant, Mateusz Gural, Constancia Esther Guy

    Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide. Besides tumor-intrinsic factors, CRC risk and progression are strongly influenced by metabolic dysfunction - including obesity, insulin resistance, and T2DM. These implications emphasize the need for therapeutic strategies that address both tumor biology and the metabolic context. Objectives: This review examines the emerging role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in colorectal cancer biology, synthesizing mechanistic, preclinical, and human evidence to evaluate their potential relevance beyond well-known glycemic control. Methods: We integrate experimental studies, animal models, and epidemiologic and clinical data to evaluate the effects of GLP-1RAs on colorectal cancer–related pathways, tumor growth and progression, and resulting clinical outcomes, with special attention given to metabolic and signaling mechanisms. Key Findings: Preclinical evidence suggests that GLP-1RAs may modulate pathways involved in cancer cell proliferation, survival, metabolism, angiogenesis, and invasion, including PI3K/Akt/mTOR, ERK, and hypoxia-associated signaling. In vivo models showcase inhibitory effects on tumor growth and metastatic potential, heightened in metabolically dysregulated settings. Human observational studies report heterogeneous but generally neutral to protective associations between GLP-1RA exposure and CRC risk, while randomized trials have primarily addressed cardiometabolic outcomes rather than being tumor-focused. Conclusions: Collectively, current evidence supports a biologically plausible role for GLP-1 receptor signaling in colorectal cancer growth and progression. Definitive clinical data are lacking, but evidence regarding GLP-1RAs justifies further investigation into their potential relevance.

  • Open Access

    THE ROLE OF NAPS AND DAYTIME SLEEPINESS IN STROKE RISK: A REVIEW OF THE LITERATURE FROM A PUBLIC HEALTH AND SLEEP-MONITORING TECHNOLOGY PERSPECTIVE

    by Maria Nowakowska, Oliwia Jerzyńska, Miszela Kałachurska, Martyna Rożek, Aleksandra Kowalewska-Kurek, Aleksandra Lisowska, Bartosz Nowak, Maria Sierant, Mateusz Gural, Constancia Esther Guy

    The aim of this review is to summarize the literature on daytime naps and their duration in relation to stroke risk, with particular emphasis on physiological mechanisms, demographic factors, and lifestyle. Analysis has shown that short naps of up to 30 minutes improve cognitive functions, blood pressure regulation, and stress hormone levels, and thus may have not only a neutral but also a beneficial effect on the human body. In contrast, long naps lasting 60–90 minutes or repeated multiple times during the day appear to significantly increase the risk of stroke, especially in older individuals with comorbidities such as diabetes, obesity, or hypertension. The mechanisms linking naps to stroke risk include changes in the autonomic nervous system, blood pressure, inflammatory status, and blood–brain barrier integrity. The authors emphasize that both nighttime sleep and daytime naps can be monitored for duration and quality using modern, widely available devices, such as wrist-worn trackers or mattress-embedded sensors, allowing objective assessment of sleep patterns and early identification of stroke risk factors. Further research is needed to develop systems for early detection of abnormal sleep and nap patterns, which could serve as a basis for implementing personalized stroke prevention strategies.

  • Open Access

    SKIN MICROBIOME IN SEBORRHEIC DERMATITIS: PATHOGENESIS, THERAPEUTIC IMPLICATIONS, AND ENVIRONMENTAL MODULATION OF DYSBIOSIS

    by Oliwia Jerzyńska, Miszela Kałachurska, Martyna Rożek, Maria Nowakowska, Aleksandra Kowalewska-Kurek, Aleksandra Lisowska, Bartosz Nowak, Maria Sierant, Mateusz Gural, Constancia Esther Guy

    Seborrheic dermatitis (SD) is one of the most commonly diagnosed inflammatory dermatoses. In recent years, the approach to the pathogenesis of SD has been expanded beyond the model describing the proliferation of fungi of the genus Malassezia as the main initiating factor. More recent studies have indicated that one of the key mechanisms is the loss of diversity of the skin microbiota, which enables the dominance of microorganisms promoting the exacerbation of disease lesions. Current reports emphasize the impact of disturbances in the composition of the skin microbiota, impairment of the epidermal barrier, and the host immune response as a complex pathomechanism. In parallel, the literature provides numerous lines of evidence indicating that environmental factors, such as pollution and lifestyle, may actively affect the skin microbiome, promoting its dysbiosis. Consequently, the environment may be considered as one of the factors actively modulating the disease and an important element in the context of personalized therapy aimed at maintaining microbiological balance. The aim of this study is to present current research describing the impact of environmental factors on the development of skin dysbiosis and to discuss a perspective focused on restoring the balance of the skin microbiota and its protective mechanisms as a potential element positively influencing the clinical presentation in patients with seborrheic dermatitis. Disruption of the skin microbiome balance constitutes a key element in the pathogenesis of seborrheic dermatitis, which justifies a therapeutic approach aimed at restoring microbiological homeostasis in order to achieve and maintain disease remission.